Gilead Sciences Inc (GILD)

Debt-to-capital ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	23,189,000	22,957,000	25,179,000	28,645,000	22,094,000
Total stockholders’ equity	US$ in thousands	22,833,000	21,240,000	21,069,000	18,202,000	22,525,000
Debt-to-capital ratio		0.50	0.52	0.54	0.61	0.50

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $23,189,000K ÷ ($23,189,000K + $22,833,000K)
= 0.50

The debt-to-capital ratio of Gilead Sciences, Inc. has fluctuated over the past five years, indicating varying levels of reliance on debt as a source of financing. The ratio decreased from 0.63 in 2020 to 0.52 in 2019, signaling potential debt reduction efforts or increased capital contributions during that period. However, the ratio then increased to 0.56 in 2021 and further to 0.54 in 2022 before slightly decreasing to 0.52 in 2023.

Overall, the trend shows a mix of reliance on debt and equity to fund the company's operations and investments. The company's ability to manage its debt levels and maintain a stable debt-to-capital ratio will be crucial in ensuring financial stability and flexibility in the long term.